D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes

(2011) C. Morgantini et al.   DIABETES

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma

(2011) David Meriwether et al.   JOURNAL OF LIPID RESEARCH

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally

(2011) Mohamad Navab et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes

(2010) C. Morgantini et al.   DIABETES

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function

(2010) Catherine E. Watson et al.   JOURNAL OF LIPID RESEARCH

Functional and pathological roles of the 12- and 15-lipoxygenases

(2010) Anca D. Dobrian et al.   PROGRESS IN LIPID RESEARCH

L-4F Alters Hyperlipidemic (But Not Healthy) Mouse Plasma to Reduce Platelet Aggregation

(2009) Georgette M. Buga et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Phosphatidylethanolamine-esterified Eicosanoids in the Mouse

(2009) Alwena H. Morgan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The enteropathy of prostaglandin deficiency

(2009) David H. Adler et al.   JOURNAL OF GASTROENTEROLOGY

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids

(2009) Mohamad Navab et al.   JOURNAL OF LIPID RESEARCH

Induction of arachidonate 12-lipoxygenase (Alox15) in intestine of iron-deficient rats correlates with the production of biologically active lipid mediators

(2008) James F. Collins et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

(2008) Brian J. Van Lenten et al.   JOURNAL OF LIPID RESEARCH

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

(2008) LeAnne T. Bloedon et al.   JOURNAL OF LIPID RESEARCH

Altered Eicosanoid Metabolism in the Cystic Fibrosis Mouse Small Intestine

(2008) Robert C De Lisle et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION